EMD Serono Inc., Merck KGaA’s North American drug development business, has officially taken up residence in Boston’s Seaport ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

Nestled in verdant greenery, the innovation hub’s like-minded community, customisable workspaces and proximity to key ...

Study Meets Overall Response Rate Primary Endpoint, Encouraging Secondary Endpoint Progression-Free Survival Data in Squamous Cell Carcinoma ...

The Francis Crick Institute and MSD (tradename of Merck & Co., Inc., Rahway ... capacity ahead of the 2027 opening of their MSD Research Laboratories, London and UK Headquarters in Kings Cross. The ...

Merck’s drug is the most successful of a ... BioNTech is also investing in new facilities near its headquarters in Mainz, Germany, that it hopes to open by the end of the year.

It was one of those conversations you never forget. We were discussing – of all things – the Covid injections, and I was questioning the early ‘safe and effective’ claims put forward by the pharmaceut ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...

Forbes Business constructed a list of the best employers by state in 2024. New Jersey's list of top employers featured 90 companies.